
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein Inc. reported a robust performance in its dental segment, achieving a revenue growth of 6.2% and an impressive increase in dental consumables revenue by 4.8%. The company's global technology segment also contributed to growth, generating $160 million and experiencing a 2.4% rise in revenue. Furthermore, the firm's outlook for adjusted EBITDA growth in mid-single digits and a forecasted increase in non-GAAP EPS indicates a positive trend leading up to 2025, reflecting an overall confidence in the company’s financial trajectory.
Bears say
Henry Schein Inc. has experienced a disappointing fourth quarter, with revenue of $3.19 billion reflecting a 5.8% increase but falling significantly short of the company's original expectation of $3.35 billion. The gross margin for the quarter was 31.1%, underperforming against the expected 31.6%, contributing to an overall earnings shortfall attributed to a weak top-line performance. Furthermore, management indicated short-term headwinds related to a shift to a SaaS model and unfavorable seasonal factors, such as the timing of Christmas and flu season, exacerbated the company's challenges during the quarter.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares